Small Animals Core
小动物核心
基本信息
- 批准号:10365961
- 负责人:
- 金额:$ 29.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-09 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAllelesAnimal ModelAnimalsAntibodiesAntibody RepertoireAntigensB cell repertoireB-LymphocytesBiological AssayBostonBypassCell CompartmentationCell MaturationComplexDevelopmentDistalEpitopesEvaluationEvolutionExclusionExonsGenesGenetic RecombinationHIVHIV-1HumanImmunizationImmunizeImmunoglobulin GenesImmunoglobulinsIn VitroIndividualKnock-inLeadLightMature B-LymphocyteMembraneMethodsModelingMusNucleotidesPediatric HospitalsPhysiologicalPopulationResearchResearch PersonnelSchemeSeriesSourceSpecificitySystemTestingV(D)J Recombinationcentral tolerancedesignefficacy testingenv Gene Productsexperienceexperimental studyfallsimmunogenicin vivomouse modelneutralizing antibodyprogramsscreening
项目摘要
Abstract - Small Animal Models Core
The objective of the Small Animals Model Core is to generate a series of mouse models that express
the unmutated common ancestor (UCA) or intermediate antibodies (IAs) of the DH511 lineage of broadly
neutralizing antibody (bnAb). These mouse models will be used to test the efficacy of immunogens that are
designed to elicit the DH511 lineage of bnAbs. Toward this end, the Animal Model Core will generate two types
of mouse models. The first type of model expresses pre-rearranged V(D)J exons of the DH511 antibodies.
Owing to allelic exclusion, the pre-rearranged DH511 V(D)J exon will inhibit the rearrangement of endogenous
mouse immunoglobulin (Ig) loci. As a result, B cells in these mice will express predominantly DH511
antibodies. One common problem for this type of mouse model is that tolerance control mechanisms delete B
cells expressing the knock-in human Ig genes. To overcome this hurdle, we have developed a method to
express human antibodies conditionally in mature B cells, thereby circumventing tolerance control during B cell
maturation. If necessary, we will employ this conditional expression system to generate DH511 mouse models.
Since this type of model provides a large population of B cells expressing DH511UCA or IAs, it would serve as
a sensitive assay for the initial evaluation of immunogens. However, the system does not recapitulate the
complexity of physiological B cell repertoire in at least two major respects. First, the unique UCA expressed in
the mouse model may not be present in a fraction of human populations. Second, the system lacks competing
antibodies for irrelevant epitopes. To address these limitations, the Animal Model Core will generate a second
type of mouse model where the VH3-15, D3-3 and JH6 gene segments of DH511 undergo de novo V(D)J
recombination. Due to junctional diversity, the recombination will create a wide range of CDR H3s, some of
which may be suitable for the development of DH511-like antibodies. Moreover, the system does not preclude
the rearrangements of endogenous mouse Ig gene segments. Therefore, the B cell repertoire of this mouse
model will consist of potential DH511 precursors as well as other human VH3-15/D3-3/JH6 and mouse
antibodies. Immunization of this mouse model could assess the ability of the immunogen to select for and
mature DH511 precursors in the context of complex antibody repertoires.
摘要-小动物模型核心
小动物模型核心的目标是产生一系列小鼠模型,
DH 511谱系的未突变的共同祖先(UCA)或中间抗体(IA),
中和抗体(bnAb)。这些小鼠模型将用于测试免疫原的功效
设计用于引出bnAb的DH 511谱系。为此,动物模型核心将产生两种类型
小鼠模型。第一种类型的模型表达DH 511抗体的预先重排的V(D)J外显子。
由于等位基因排斥,预先重排的DH 511 V(D)J外显子将抑制内源性DNA的重排。
小鼠免疫球蛋白(IG)基因座。结果,这些小鼠中的B细胞将主要表达DH 511
抗体的这类小鼠模型的一个常见问题是公差控制机制删除了B
表达敲入的人IG基因的细胞。为了克服这一障碍,我们开发了一种方法,
在成熟B细胞中有条件地表达人抗体,从而避开B细胞过程中的耐受控制,
成熟如有必要,我们将使用该条件表达系统来生成DH 511小鼠模型。
由于这种类型的模型提供了大量表达DH 511 UCA或IA的B细胞群体,因此它将用作
用于免疫原初步评估的灵敏测定法。然而,该系统并没有概括
生理B细胞库在至少两个主要方面的复杂性。第一,独特的UCA表达在
小鼠模型可能不存在于一部分人类群体中。第二,系统缺乏竞争
不相关表位的抗体。为了解决这些限制,动物模型核心将产生第二个
一种小鼠模型,其中DH 511的VH 3 -15、D3-3和JH 6基因片段经历从头V(D)J
重组由于连接多样性,重组将产生宽范围的CDR H3,其中一些是
其可能适合于开发DH 511样抗体。此外,该系统不排除
内源性小鼠IG基因片段的重排。因此,这只小鼠的B细胞库
模型将由潜在的DH 511前体以及其他人VH 3 -15/D3-3/JH 6和小鼠VH 3 -15/D3-3/JH 6组成。
抗体的该小鼠模型的免疫可以评估免疫原选择和免疫应答的能力。
成熟DH 511前体在复杂抗体库中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
S. Munir ALAM其他文献
S. Munir ALAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('S. Munir ALAM', 18)}}的其他基金
Project 2 - B cell antigen receptor structure and antigen-BCR interaction dynamics
项目2-B细胞抗原受体结构和抗原-BCR相互作用动力学
- 批准号:
10506668 - 财政年份:2022
- 资助金额:
$ 29.39万 - 项目类别:
Project 2 - B cell antigen receptor structure and antigen-BCR interaction dynamics
项目2-B细胞抗原受体结构和抗原-BCR相互作用动力学
- 批准号:
10643921 - 财政年份:2022
- 资助金额:
$ 29.39万 - 项目类别:
Antigen recognition and activation of B-cell receptors of HIV-1 broadly neutralizing antibodies
HIV-1 广泛中和抗体的 B 细胞受体的抗原识别和激活
- 批准号:
10338128 - 财政年份:2019
- 资助金额:
$ 29.39万 - 项目类别:
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
用于诱导 HIV 远端 gp41 广泛中和抗体的免疫原设计
- 批准号:
10597091 - 财政年份:2019
- 资助金额:
$ 29.39万 - 项目类别:
Project 2. Animal studies to elucidate the optimal sequence of Env immunogens for induction of distal MPER bnAbs
项目 2. 阐明用于诱导远端 MPER bnAb 的 Env 免疫原最佳序列的动物研究
- 批准号:
10597100 - 财政年份:2019
- 资助金额:
$ 29.39万 - 项目类别:
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
用于诱导 HIV 远端 gp41 广泛中和抗体的免疫原设计
- 批准号:
10132973 - 财政年份:2019
- 资助金额:
$ 29.39万 - 项目类别:
Project 2. Animal studies to elucidate the optimal sequence of Env immunogens for induction of distal MPER bnAbs
项目 2. 阐明用于诱导远端 MPER bnAb 的 Env 免疫原最佳序列的动物研究
- 批准号:
10365963 - 财政年份:2019
- 资助金额:
$ 29.39万 - 项目类别:
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
用于诱导 HIV 远端 gp41 广泛中和抗体的免疫原设计
- 批准号:
9912097 - 财政年份:2019
- 资助金额:
$ 29.39万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 29.39万 - 项目类别:
Continuing Grant